samedan logo
 
 
 
spacer
home > ebr > winter 2002 > realising the potential of human cells for therapy
PUBLICATIONS
European Biopharmaceutical Review

Realising the Potential of Human Cells for Therapy

Cell therapy offers the potential to revolutionise health care. Instead of taking medicines that address only the symptoms of chronic disease, cell implants and engineered tissues will be able to cure a broad range of health conditions. The potential returns, both in terms of clinical benefit and financial reward, are significant. Not only can cell therapies displace expensive medicines, they can also greatly reduce the costs of supporting patients on long-term medical regimes. This is not a theoretical proposition - cell and cell-derived therapies are already being used effectively for a variety of applications.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Will West, Product Development Director at CellFactors Dr Will West is Product Development Director at CellFactors plc, where his main focus has been on developing and commercialising SkeletexTM, a human cell-derived matrix that induces bone formation.
His scientific background is in immunology, virology and cell culture, and he completed his PhD, sponsored by Unilever (UniPath), in 1992. Following this, Dr West held a post-doctoral position at the National Institute of Biological Standards and Control, working on HIV vaccines and MHC proteins. Dr West subsequently worked at Procter & Gamble, responsible for product and claims development in a number of health care therapeutic areas. He has an MBA from London Business School.

spacer
Dr Will West
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

EXTERNAL COMMUNICATION, 24 October 2019, Copenhagen, Denmark PRESS RELEASE – FLYPHARMA CONFERENCE EUROPE 2019

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices, putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical logistics and an exploration of the industry’s digitalisation and innovation.
More info >>

White Papers

8 Ways To Reduce Tablet Manufacturing Costs

Natoli Engineering Company, Inc.

It’s no surprise that in today’s economy, companies are facing budget cuts across the board. In an effort to address these challenges, this list of 8 Ways to Reduce Tablet Manufacturing Costs was compiled.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement